09:33 AM EST - BioVaxys Technology Corp : Announces that the Company and Horizon Technology Finance Corporation have executed a follow-on Amendment to the Asset Purchase Agreement dated February 11th, 2024 for acquiring the entire portfolio of assets and intellectual property based on the DPX™ immune educating platform technology developed by Canadian biotechnology company, IMV Inc. BioVaxys Technology Corp
shares C.BIOV are trading unchanged at $0.04.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=BIOV%3ACC&qmodStoryID=8068986157278261
